Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Company will host a Conference call for Analysts and Investors to discuss the Un-audited financial results of the Company for the quarter ended September 30, 2025 on Thursday, November 13, 2025 at 04:00 p.m. (IST)
ADVENZYMES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Advanced Enzyme Technologies has scheduled a conference call for analysts and investors on Thursday, November 13, 2025 at 4:00 PM IST. The call will cover the company's unaudited financial results for the quarter ended September 30, 2025 (Q2 FY26). This is a standard disclosure under SEBI listing regulations informing the market about the upcoming results discussion. No financial figures or business updates have been shared in this announcement.
This is a routine pre-earnings communication and is unlikely to move the stock on its own. Investors should watch the actual Q2 FY26 results, which are expected to be shared around the same date, for any meaningful impact on the share price.